NLS Norway

Collaboration - April 5, 2022

OCC Incubator collaborates with Rebel

Rebel and Oslo Cancer Cluster Incubator have started a collaboration to tighten the ties between cancer research and information technology. Rebel connects information technology- and software developers in the centre of Oslo. Since the hub opened last autumn, they have experienced that the need for technological competencies in Oslo is massive, also in the health […]

In a new job - March 29, 2022

He is the new CEO of Exact Therapeutics

EXACT Therapeutics has announced that its Board of Directors has appointed Per Walday as Chief Executive Officer. Per Walday has experience from research to commercialization of therapeutics and medical devices globally, including drug-device combination within the field of oncology. “The Board and I are very excited to welcome Per as CEO of EXACT-Tx. He brings […]

Clinical Trials - March 28, 2022

First expansion cohort in IMPRESS-Norway

The Regional Health Authorities in Norway has recently decided to reimburse patients who are included in the first expansion cohort in IMPRESS-Norway according to a pay-for-performance model. IMPRESS-Norway is a precision medicine trial that tests approved drugs on new indications based on genetic changes in the patient’s tumor. The study started in April last year, […]

Business article - March 21, 2022

Targovax proposes a drop-down demerger

The Board of Directors of Targovax has signed a joint demerger and merger plan, respectively, for the transfer of the operational activities of the company to its wholly-owned subsidiary, Targovax Solution AS. The transfer is proposed carried out as a “drop-down demerger” where the company demergers operations and assets to its subsidiary Athomstart Invest 586 […]

Business article - March 9, 2022

University of Oslo’s Life Science Growth House is now open

Tailored counseling, funding assistance, and innovation hangouts are part of the innovation package offered by the new Life Science Growth House at the University of Oslo. “The Life Science Growth House is about utilizing the research. We are good at research, but we can become even better at transferring that knowledge to innovation and making […]

Business article - January 1, 2022

Real-World Evidence – The time is now

Nordic Life Science asked the newly formed company NordicRWE about the potential of Real-World Evidence in drug development and how we can better enable Nordic health data to be transformative and a frontrunner in this field. The amount of health-related data is rapidly increasing. At the same time, the healthcare sector is facing major challenges: […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.